Jiong Zhou

Prof. Dr. Jiong Zhou

Department of Chemistry, College of Sciences, Northeastern University, Shenyang 110819, China
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2017 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
Jiong ZhouJiong Zhou
Jiong Zhou
GYGuocan Yu
Guocan Yu
FHFeihe Huang
Feihe Huang
This review highlights the progress of supramolecular chemotherapy in cancer treatment based on host–guest interactions and provides guidance on the design of new targeting supramolecular chemotherapy combining diagnostic and therapeutic functions.

1 February 2021 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
Jiong ZhouJiong Zhou
Jiong Zhou
LRLang Rao
Lang Rao
GYGuocan Yu
Guocan Yu
TCTimothy R Cook
Timothy R Cook
XCXiaoyuan Chen
Xiaoyuan Chen
FHFeihe Huang
Feihe Huang
Supramolecular cancer nanotheranostics have shown promising potentials in early-stage diagnosis and personal therapy. Herein, we summarize the progress of supramolecular cancer nanotheranostics and provide guidance for designing new targeted supramolecular theranostic agents.

31 December 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
BSBingbing Shi
Bingbing Shi
KJKecheng Jie
Kecheng Jie
YZYujuan Zhou
Yujuan Zhou
Jiong ZhouJiong Zhou
Jiong Zhou
DXDanyu Xia
Danyu Xia
FHFeihe Huang
Feihe Huang

6 June 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GYGuocan Yu
Guocan Yu
XZXinlian Zhao
Xinlian Zhao
Jiong ZhouJiong Zhou
Jiong Zhou
ZMZhengwei Mao
Zhengwei Mao
XHXiaolin Huang
Xiaolin Huang
XCXiaoyuan Chen
Xiaoyuan Chen

22 May 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
Jiong ZhouJiong Zhou
Jiong Zhou
YZYuzhen Zhang
Yuzhen Zhang
GYGuocan Yu
Guocan Yu
MCMatthew Crawley
Matthew Crawley
CFCressa Ria P. Fulong
Cressa Ria P. Fulong
TCTimothy R Cook
Timothy R Cook

18 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
GYGuocan Yu
Guocan Yu
SYShan Yu
Shan Yu
MSManik Lal Saha
Manik Lal Saha
Jiong ZhouJiong Zhou
Jiong Zhou
TCTimothy R Cook
Timothy R Cook
XCXiaoyuan Chen
Xiaoyuan Chen
Photodynamic therapy is an effective alternative to traditional treatments due to its minimally invasive nature, negligible systemic toxicity, fewer side effects, and avoidance of drug resistance. However, it is still challenging to design photosensitizers with high singlet oxygen (1O2) quantum yields (QY) due to severe aggregation of the hydrophobic photosensitizers. Herein, we developed a discrete organoplatinum(II) metallacage using therapeutic cis-(PEt3)2Pt(OTf)2 as the building block to improve the 1O2 QY, thus achieving synergistic anticancer efficacy. The metallacage-loaded nanoparticles (MNPs) with tri-modality imaging capability allow precise diagnosis of tumor and real-time monitoring the delivery, biodistribution, and excretion of the MNPs. MNPs exhibited excellent anti-metastatic effect and superior anti-tumor performance against U87MG, drug resistant A2780CIS, and orthotopic tumor models, ablating the tumors without recurrence after a single treatment. Gene chip analyses confirmed the contribution of different therapeutic modalities to the tumor abrogation. This supramolecular platform holds potential in precise cancer theranostics.